Topical and intratumoral photodynamic therapy with 5-aminolevulinic acid in a subcutaneous murine mammary adenocarcinoma

Cancer Letters

Volumn 141, Issue 1-2, 1999, Pages 29-38

  Casas, Adriana ^a   Fukuda, Haydée ^a   Meiss, Roberto ^b   Del C Batlle, Alcira M ^a  

^a Univ Nac Cordoba Cd Univ 5000   (Argentina)

^b ACADEMIA NACIONAL DE MEDICINA   (Argentina)

Author keywords

Aminolevulinic acid; Intratumour injection; Photodynamic therapy (PDT); Subcutaneous transplantable tumour; Topical application

Indexed keywords

AMINOLEVULINIC ACID; PORPHYRIN;

ANIMAL MODEL; ARTICLE; BREAST ADENOCARCINOMA; CONTROLLED STUDY; DRUG EFFICACY; HISTOLOGY; INTRATUMORAL DRUG ADMINISTRATION; LASER; MALE; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; SKIN; TOPICAL DRUG ADMINISTRATION;

ADENOCARCINOMA; ADMINISTRATION, TOPICAL; AMINOLEVULINIC ACID; ANIMALS; CELL DIVISION; INJECTIONS, INTRALESIONAL; LASERS; MALE; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; NEOPLASM TRANSPLANTATION; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; SKIN; SKIN NEOPLASMS; TIME FACTORS;

MURINAE;

EID: 0032978292     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(99)00079-8     Document Type: Article

References (28)

1. Boehncke W., Sterry R., Kaufmann R. Treatment of psoriasis by topical photodynamic therapy with polychromatic light. Lancet. 343:1994;801. (Letter).
2. Cairnduff F., Stringer M., Hudson E., Ash D., Brown S. Superficial photodynamic therapy with topical 5-aminolevulinic acid for superficial primary and secondary skin cancer. Br. J. Cancer. 69:1994;605-608.
3. Cairnduff F., Roberts D.J., Dixon B., Brown S.B. Response of a rodent fibrosarcoma to photodynamic therapy using 5-aminolaevulinic acid or polyhematoporphyrin. Int. J. Radiat. Biol. 67:1995;93-99.
4. Divaris D., Kennedy J., Pottier R. Phototoxic damage to sebaceous glands and hair follicles of mice after systemic administration of 5-aminolaevulinic acid correlates with localized protoporphyrin IX fluorescence. Am. J. Pathol. 136:1990;891-897.
5. Falk J. Porphyrins and metalloporphyrins. Biochim. Biophys. Acta Library. 2:1964;Elsevier, Amsterdam.
6. Fukuda H., Paredes S., Batlle A. Tumour-localizing properties of porphyrins. In vivo studies using free and liposome encapsulated aminolevulinic acid. Comp. Biochem. Physiol. 102B:1992;433-436.
7. Fukuda H., Paredes S., Casas A., Chueke F., Batlle A. Potential of liposome-entrapped aminolevulinic acid in cancer therapy. Effect of prior injection of empty liposomes and different routes of administration. Cancer J. 5:1992;295-299.
8. Grant E.W., Hopper A.J., MacRobert A.J., Speight P.M., Bown S.G. Photodynamic therapy of oral cancer: photosensitization with systemic aminolevulinic acid. Lancet. 342:1993;147-148.
9. He X.-Y., Sikes R.A., Thomsen S., Chung L.W., Jacques S.L. Photodynamic therapy with Photofrin II induces programmed cell death in carcinoma cell lines. Photochem. Photobiol. 59:1994;468-473.
10. Henderson B.W., Vaughan L., Bellnier D., Van Leengoed H., Johnson P.G., Oseroff A.R. Photosensitization of murine tumour, vasculature and skin by 5-aminolevulinic acid-induced porphyrin. Photochem. Photobiol. 62:1995;780-789.
11. Henderson B.W., Dougherty T.J. How does photodynamic therapy work? Photochem. Photobiol. 55:1992;145-157.
12. Heyerdahl H., Wang I., Lin D.L., Berg R., Andersson-Engels S., Peng Q., Moan J., Savnberg S., Svanberg K. Pharmacokinetic pattern studies on 5-aminolevulinic acid-induced Protoporphyrin IX accumulation in tumours and normal tissues. Cancer Lett. 112:1997;225-231.
13. Kennedy J., Pottier R. Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. J. Photochem. Photobiol. B. 14:1992;275-292.
14. Krammer B., Überriegler K. In-vitro investigation of ALA-induced protoporphyrin IX. J. Photochem. Photobiol. B. 36:1996;121-126.
15. Mlkvy P., Messmann H., Regula J., Cories M., Paner M., Millson C.E., MacRobert A.J., Bown S.G. Sensitization and photodynamic therapy (PDT) of gastrointestinal tumours with 5-aminolevulinic acid (ALA) induced protoporphyrin IX (PPIX). A pilot study. Neoplasma. 42:1995;109-113.
16. Moan J., Sommer S. Oxygen dependence of the photosensitizing effect of hematoporphyrin derivative in NHIK 3025 cells. Cancer Res. 45:1985;1608-1610.
17. Navone N., Polo C., Dinger R., Batlle A. Heme regulation in mouse mammary adenocarcinoma and liver of tumour-bearing mice. I. Effect of allyl-isopropylacetamide and veronal on 5-aminolevulinate synthetase, cytochrome P450 and cytochrome oxidase. Int. J. Biochem. 22:1990;1005-1012.
18. Noodt B.B., Berg K., Stokke T., Peng Q., Nesland J.M. Apoptosis and necrosis induced with light and 5-aminolaevulinic acid-derived protoporphyrin IX. Br. J. Cancer. 74:1996;22-29.
19. Peng Q., Moan J., Warloe T., Nesland J.M., Rimington C. Distribution and photosensitizing efficiency of porphyrins induced by application of exogenous 5-aminolevulinic acid in mice bearing mammary carcinoma. Int. J. Cancer. 52:1992;433-443.
20. Peng Q., Warloe T., Moan J., Heyerdahl H., Steen H.B., Nesland J.M., Giercksky K.E. Distribution of 5-aminolevulinic acid-induced porphyrins in nodulo-ulcerative basal cell carcinoma. Photochem. Photobiol. 62:1995;906-913.
21. Peters G., Nadal J., Pinedo H. Diurnal variation in the therapeutic efficacy of 5-fluorouracil against murine colon cancer. In Vivo. 1:1987;113-118.
22. Rimington C. Spectral absorption coefficients of some porphyrins in the Soret band region. Biochem. J. 75:1960;620-623.
23. Scolnik A., Rubio M., Colombo L., Comolli R., Caro R. Further studies on the histamine metabolism in the M2 adenocarcinoma. Biomed. Pharmacother. 38:1984;465-467.
24. Star W.M., Marijnissen H.P., Van Der Berg-Block A.E., Versteeg J.A., Franken K.A., Reinhold H.S. Destruction of rat mammary tumour and normal tissue microcirculation by HPD photoradiation observed in vivo in sandwich observation chambers. Cancer Res. 46:1986;2532-2540.
25. Stringer M., Collins P., Robinson D., Stables G., Sheehan-Dare R. The accumulation of Protoporphyrin IX in plaque psoriasis after topical application of 5-aminolevulinic acid indicates a potential for superficial photodynamic therapy. J. Invest. Dermatol. 107:1996;76-81.
26. Szeimies R.M., Karrer S., Sauerwald A., Landthaler M. Photodynamic therapy with topical application of 5-aminolevulinic acid in the treatment of actinic keratoses: an initial clinical study. Dermatology. 192:1996;246-251.
27. UK-Coordinating Committee on Cancer Research (1988), UKCCCR Guidelines for the Welfare of Animals in Experimental Neoplasia. UKCCCR, London.
28. Webber J., Luo Y., Crilly R., Fromm D., Kessel D. An apoptotic response to photodynamic therapy with endogenous protoporphyrin in vivo. J. Photochem. Photobiol. B. 35:1996;209-211.